Sales and Marketing

Showing 15 posts of 11526 posts found.

GSK tops access to medicines ranking

June 21, 2010 Sales and Marketing GlaxoSmithKline, developing world, medicines access

GlaxoSmithKline does the most of any pharma manufacturer to improve access to medicines needed in the developing world, according to …

Tasigna more effective than Glivec, says Novartis

June 21, 2010 Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia

Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …
Ecteinascidia turbinata

NICE rejects Yondelis in ovarian cancer

June 21, 2010 Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer

New cancer treatment Yondelis has been rejected by NICE in a preliminary ruling on its use in relapsed ovarian cancer. …

Prolia gets early thumbs up from NICE

June 18, 2010 Sales and Marketing Amgen, NICE, Prolia

Amgen’s new treatment to prevent bone fractures caused by osteoporosis has been given preliminary approval from the UK’s cost effectiveness …

ABPI appoints former AZ innovation head

June 17, 2010 Research and Development, Sales and Marketing ABPI, appointment, research and development, sales and marketing

UK industry association the ABPI has appointed Carol Blount as its new head of commercial affairs. Carol has more than …
Tom McKillop and Fred Goodwin

Reinventing Management

June 17, 2010 Research and Development, Sales and Marketing management

The investment banking industry officially ceased to exist on September 21, 2008. That was the day the last two remaining …
Tarceva

NICE rejects Tarceva maintenance treatment

June 17, 2010 Sales and Marketing NICE, NSCLC, Roche, Tarceva, lung cancer

Roche’s Tarceva should not be used in lung cancer patients who have already been treated and whose disease remains stable, …

FDA to make safety reviews public

June 16, 2010 Research and Development, Sales and Marketing FDA, drug safety

The US medicines regulator is to make safety reviews of recently approved prescription medicines more readily available to the public. …

Novo agrees price cut deal with Greece

June 16, 2010 Sales and Marketing Greece, Novo Nordisk, insulin, pricing

Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …

GSK’s Votrient approved in Europe

June 16, 2010 Sales and Marketing GlaxoSmithKline, Kidney cancer, Votrient

The European Commission has granted a conditional marketing authorisation for a GlaxoSmithKline drug that treats the most common form of …

Patrick Walker appointed to PPRS resolution panel

June 16, 2010 Sales and Marketing DH, UK, appointment, sales and marketing

The Department of Health has appointed Patrick Walker to chair the Dispute Resolution Panel for UK pricing system the Pharmaceutical …
Victoza pack

Victoza wins partial NICE recommendation

June 15, 2010 Sales and Marketing NICE, Victoza, diabetes

Novo Nordisk has been given a limited approval for its new type II diabetes treatment in draft guidance issued by …
Blog footer

Digital Pharma: Janssen gets animated about ADHD

June 14, 2010 Medical Communications, Sales and Marketing ADHD, Janssen, disease awareness campaigns

Janssen-Cilag has launched a new UK campaign to raise awareness of ADHD among teenagers, their parents and teachers. The campaign’s …

Boehringer denies Micardis cancer link

June 14, 2010 Sales and Marketing ACE-inhibitors, ARB, Boehringer, Micardis, drug safety

Boehringer Ingelheim has given a robust rebuttal to a Lancet report implicating its hypertension drug Micardis (telmisartan) in scares about …

Implementing value-based pricing in the UK

June 14, 2010 Sales and Marketing hta, pricing, value

The UK has a strong history of innovation in medicines and it is vital to the economy that this continues …
The Gateway to Local Adoption Series

Latest content